Cargando…
EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
Therapeutic options for advanced stage cholangiocellular carcinoma (CCC) are very limited as of today and patients carry an exceptionally poor overall prognosis. In recent years, increasing evidence has been accumulated to suggest that malignant cells widely show increased intrinsic ROS levels and e...
Autores principales: | Bisht, Savita, Nolting, Jens, Wenzel, Jörg, Brossart, Peter, Feldmann, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425401/ https://www.ncbi.nlm.nih.gov/pubmed/30949204 http://dx.doi.org/10.1155/2019/8701824 |
Ejemplares similares
-
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
por: Bisht, Savita, et al.
Publicado: (2016) -
Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread—Identification of a Promising Novel therapeutic target()
por: Bisht, Savita, et al.
Publicado: (2015) -
Rpl24(Bst) mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K
por: Knight, John RP, et al.
Publicado: (2021) -
Mitochondriome and Cholangiocellular Carcinoma
por: Bahitham, Wesam, et al.
Publicado: (2014) -
EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells
por: Zou, Peng, et al.
Publicado: (2016)